CAR19BCMA CAR-T cells

· Chinese PLA General Hospital

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for CAR19BCMA CAR-T cells, covering 2025-07-22 to 2026-04-08. Get the full timeline:

Most recent: Clinical Trial Update: CAR19BCMA CAR-T Cells for the Treatment of R/R Plasma Cell Neoplasms and Lymphomas/Leukemias With Plasmacytic Differentiation [EARLY_Phase 1]

See pricing